107 related articles for article (PubMed ID: 6552202)
21. Evaluation of alternative pathway and factor B haemolytic activities in patients with systemic lupus erythematosus: correlations with the alternative pathway regulatory proteins.
Aguado MT; Perrin LH; Ramirez R; Miescher PA; Lambert PH
Clin Exp Immunol; 1980 Dec; 42(3):495-505. PubMed ID: 6163579
[TBL] [Abstract][Full Text] [Related]
22. Defective complement activity in chronic lymphocytic leukemia.
Heath ME; Cheson BD
Am J Hematol; 1985 May; 19(1):63-73. PubMed ID: 3845763
[TBL] [Abstract][Full Text] [Related]
23. A novel ELISA for the assessment of classical pathway of complement activation in vivo by measurement of C4-C3 complexes.
Zwirner J; Dobos G; Götze O
J Immunol Methods; 1995 Oct; 186(1):55-63. PubMed ID: 7561148
[TBL] [Abstract][Full Text] [Related]
24. [Serum complement component change in patients with schistosomiasis and its clinical significance].
Wang RY; Tu YX
Zhonghua Yi Xue Za Zhi; 1987 Oct; 67(10):568-9. PubMed ID: 3127011
[No Abstract] [Full Text] [Related]
25. Immune complexes and the complement factors C4 and C3 in cerebrospinal fluid and serum from patients with chronic progressive multiple sclerosis.
Jans H; Heltberg A; Zeeberg I; Kristensen JH; Fog T; Raun NE
Acta Neurol Scand; 1984 Jan; 69(1):34-8. PubMed ID: 6702418
[TBL] [Abstract][Full Text] [Related]
26. Alterations in C3, C4, factor B, and related metabolites in septic shock.
Lin RY; Astiz ME; Saxon JC; Saha DC; Rackow EC
Clin Immunol Immunopathol; 1993 Nov; 69(2):136-42. PubMed ID: 8403550
[TBL] [Abstract][Full Text] [Related]
27. Relationship between secretory IgA, IgA-containing (C3-fixing) circulating immune complexes, and complement components (C3, C4) in patients with obstructive jaundice.
Ohshio G; Furukawa F; Manabe T; Tobe T; Hamashima Y
Scand J Gastroenterol; 1986 Mar; 21(2):151-7. PubMed ID: 3715384
[TBL] [Abstract][Full Text] [Related]
28. Studies on the mechanism producing solubilization of immune precipitates in the serum of patients with primary IgA nephropathy.
Schena FP; Pastore A; Sinico RA; Ladisa N; Montinaro V; Fornasieri A
Semin Nephrol; 1987 Dec; 7(4):336-40. PubMed ID: 3445011
[No Abstract] [Full Text] [Related]
29. [Changes of the complement system in myelodysplastic syndromes].
Villaescusa Blanco R; Arce AA; Santos RM; Fernández N
Sangre (Barc); 1998 Jun; 43(3):210-2. PubMed ID: 9741227
[TBL] [Abstract][Full Text] [Related]
30. [Serum complement levels in patients with rheumatoid arthritis and vasculitis].
Tomooka K
Fukuoka Igaku Zasshi; 1989 Oct; 80(10):456-66. PubMed ID: 2613159
[TBL] [Abstract][Full Text] [Related]
31. Cardiopulmonary bypass and complement activation. Involvement of classical and alternative pathways.
Jones HM; Matthews N; Vaughan RS; Stark JM
Anaesthesia; 1982 Jun; 37(6):629-33. PubMed ID: 6920244
[TBL] [Abstract][Full Text] [Related]
32. Circulating immune complexes in chronic myeloid leukemia patients at various stages of the disease.
Saranath D; Advani S; Gangal S
Leuk Res; 1983; 7(6):771-7. PubMed ID: 6607388
[TBL] [Abstract][Full Text] [Related]
33. Complement haemolytic activity, circulating immune complexes and the morbidity of sickle cell anaemia.
Anyaegbu CC; Okpala IE; Aken'ova AY; Salimonu LS
APMIS; 1999 Jul; 107(7):699-702. PubMed ID: 10440069
[TBL] [Abstract][Full Text] [Related]
34. Elevated IgG and decreased complement component C3 and factor B in B-thalassaemia major.
Sinniah D; Yadav M
Acta Paediatr Scand; 1981 Jul; 70(4):547-50. PubMed ID: 6914868
[TBL] [Abstract][Full Text] [Related]
35. Circulating immune complexes and rheumatoid factors in patients with farmer's lung.
Terho EO; Lindström P; Mäntyjärvi R; Tukiainen H; Wager O
Allergy; 1983 Jul; 38(5):347-52. PubMed ID: 6351661
[TBL] [Abstract][Full Text] [Related]
36. Relationship of C3 & C4 levels with filarial immune complexes in bancroftian filariasis.
Prasad GB; Harinath BC
Indian J Med Res; 1989 Sep; 89():322-5. PubMed ID: 2697689
[TBL] [Abstract][Full Text] [Related]
37. Reflection of disease activity in rheumatoid arthritis by indices of activation of the classical complement pathway.
Makinde VA; Senaldi G; Jawad AS; Berry H; Vergani D
Ann Rheum Dis; 1989 Apr; 48(4):302-6. PubMed ID: 2785367
[TBL] [Abstract][Full Text] [Related]
38. Bell's palsy: an immune complex disease.
Larsson A; Jonsson L; Sjöquist J
ORL J Otorhinolaryngol Relat Spec; 1990; 52(3):164-7. PubMed ID: 2141682
[TBL] [Abstract][Full Text] [Related]
39. Circulating immune complexes in patients with uncomplicated group A streptococcal pharyngitis and patients with acute poststreptococcal glomerulonephritis.
Yoshizawa N; Treser G; McClung JA; Sagel I; Takahashi K
Am J Nephrol; 1983; 3(1):23-9. PubMed ID: 6340506
[TBL] [Abstract][Full Text] [Related]
40. Complement activation during an active cytomegalovirus infection after renal transplantation: due to circulating immune complexes or alternative pathway activation?
van Son WJ; van der Bij W; Tegzess AM; Anema J; van der Giessen M; van der Hem GK; Marrink J; The TH
Clin Immunol Immunopathol; 1989 Jan; 50(1 Pt 1):109-21. PubMed ID: 2535976
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
